ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO1228

Integrated Spatial and Single-Cell Transcriptomics of Human Kidney Biopsies Reveals Distinct Immune Architecture in Immune Checkpoint Inhibitor-Associated Acute Interstitial Nephritis

Session Information

Category: Onconephrology

  • 1600 Onconephrology

Authors

  • Arai, Hiroyuki, Washington University in St Louis, St. Louis, Missouri, United States
  • Qin, Qian, Brigham and Women's Hospital, Boston, Massachusetts, United States
  • Gao, Ce, Brigham and Women's Hospital, Boston, Massachusetts, United States
  • Tran, Miles, Brigham and Women's Hospital, Boston, Massachusetts, United States
  • Shah, Sujal I., Brigham and Women's Hospital, Boston, Massachusetts, United States
  • Wei, Kevin, Brigham and Women's Hospital, Boston, Massachusetts, United States
  • Murakami, Naoka, Washington University in St Louis, St. Louis, Missouri, United States
Background

Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, yet their clinical benefit is hampered by immune-related adverse events (irAEs). Clinical characteristics of renal irAE, particularly ICI-associated acute interstitial nephritis (ICI-AIN), are well reported, but its underlying mechanisms remain poorly understood.

Methods

To elucidate the multicellular interactions driving ICI-AIN, we integrated CosMx high-plex spatial transcriptomics (319,141 cells) with single-cell formalin-fixed, paraffin embedded (FFPE) RNA sequencing (10X Genomics Flex (Fixed RNA) Assay; scFFPE) (61,391 cells) of paired FFPE kidney biopsy specimens from four cases; two ICI-AIN, one drug-induced AIN, one acute T cell-mediated rejection (TCMR). scFFPE-derived transcriptional signatures were projected onto CosMx data to integrate transcriptome-wide profiling with spatially resolved tissue analysis. We investigated ICI-AIN-specific transcriptomic alterations by analyzing integrated datasets of CosMx and scFFPE.

Results

scFFPE profiling revealed ICI-AIN-specific transcriptional programs across tubular, immune, and myeloid lineages, including co-inhibitory receptor signature, myeloid activation signature, and tubular injury-associated programs. Projection of these signatures on CosMx data demonstrated distinct differentially expressed gene signatures in ICI-AIN compared to drug-induced AIN and TCMR, consistently across both platforms. Spatial analysis uncovered a distinct immune architecture in ICI-AIN, including increased immune enrichment near tubular epithelial cells and enhanced proximity between co-inhibitory-high T cells and activated myeloid cells. Expression of CXCR3 and its ligands CXCL9 and CXCL10 was enriched in ICI-AIN, suggesting their potential roles in its pathogenesis.

Conclusion

Our study demonstrates that ICI-AIN exhibits a spatially organized immune architecture within peritubular regions, through integration of paired scFFPE transcriptomics and CosMx spatial profiling of kidney biopsies. CXCL9/10–CXCR3 axis may play an important role in the pathogenesis of ICI-AIN. This multimodal framework provides a foundation for analyzing human kidney biopsy specimens by leveraging the complementary strengths of spatial transcriptomics and scFFPE.

Funding

  • NIDDK Support